Related Experiment Video
Updated: Aug 12, 2026

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
Published on: March 19, 2016
[Therapeutic thrombocytapheresis--effect on hemorheologic parameters]
R Langer1, D Gross, B Mansouri Taleghani
1Abteilung Experimentelle Chirurgie, Chirurgische Universitätsklinik, Würzburg, Deutschland.
Abstract:
Common features of all myeloproliferative diseases (CMPE) are a markedly increased number of platelets and restrictions in the subjective feeling of the patients, comprising symptoms like nausea, headache, sensory deficits and transient paresis. Meanwhile, it has been shown that platelet pheresis (mTD) does not only reduce platelet counts sufficiently but also results in an impressive relief of the subjective complaints. To test the part that rheological mechanisms play hereby, relevant rheological parameters in the blood of 22 CMPE patients and of 8 healthy platelet donors as controls were analyzed before and after treatment with an AS-104 cell separator. Concerning the viscosity of whole blood und the filterability of erythrocytes, there was seen neither a difference between the patients and the controls, nor before and after mTD. As a result of treatment of patients, the moderately raised plasma viscosity was normalized, whereas the aggregation of erythrocytes was significantly lowered. It is concluded that there is an influence of hemorheological conditions on the patient's subjective feeling. These would originate in neurological dysfunctions caused by CMPE-induced restrictions in cortical microcirculation. The erythrocyte aggregation, lowered by mTD, would cause an improvement of microcirculatory fluidity and would, in consequence, abolish the neurological symptoms.
Insights
Platelet pheresis (mTD) effectively alleviates myeloproliferative disease symptoms by improving blood flow. This treatment normalizes plasma viscosity and reduces erythrocyte aggregation, easing neurological discomfort.
Area of Science:
- Hematology
- Neurology
- Rheology
Context:
- Myeloproliferative diseases (CMPE) are characterized by high platelet counts and debilitating subjective symptoms.
- Platelet pheresis (mTD) is a treatment that reduces platelet levels and improves patient well-being.
Purpose:
- To investigate the role of rheological mechanisms in CMPE symptom relief following platelet pheresis.
- To analyze blood rheological parameters before and after mTD in CMPE patients.
Summary:
- While whole blood viscosity and erythrocyte filterability remained unchanged, mTD normalized moderately elevated plasma viscosity in CMPE patients.
- A significant reduction in erythrocyte aggregation was observed post-mTD treatment.
- No significant differences in rheological parameters were found between patients and controls before treatment.
Impact:
- Hemorheological factors significantly influence subjective symptoms in CMPE patients.
- Reduced erythrocyte aggregation improves microcirculatory fluidity, potentially alleviating neurological symptoms.
- Findings suggest neurological dysfunction due to restricted cortical microcirculation is linked to CMPE symptoms.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis III: Interprofessional Care

